| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone (Viatris) 4 mg/mL injection, 1 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| meningococcal A 10 microgram/0.5 mL + meningococcal C 10 microgram/0.5 mL + meningococcal W135 10 microgram/0.5 mL + meningococcal Y 10 microgram/0.5 mL conjugate vaccine injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Menquadfi injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alfentanil (Hameln) 5 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alfentanil (Hameln) 1 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vosoritide 560 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vosoritide 400 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vosoritide 1.2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dostarlimab 500 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Jemperli 500 mg/10 mL injection, 10 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| patisiran 10 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Onpattro 10 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Rybrevant 350 mg/7 mL injection, 7 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| edaravone 30 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| somapacitan 10 mg/1.5 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Radicava 30 mg/20 mL injection, 20 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| amivantamab 350 mg/7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Sogroya 10 mg/1.5 mL injection, 1.5 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| damoctocog alfa pegol 1000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| damoctocog alfa pegol 3000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| damoctocog alfa pegol 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| damoctocog alfa pegol 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| damoctocog alfa pegol 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| enfortumab vedotin 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Sunlenca 463.5 mg/1.5 mL injection, 1.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| enfortumab vedotin 30 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lenacapavir 463.5 mg/1.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Levetiracetam (Medsurge) 500 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Metoprolol IV (Viatris) 5 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 1 g/40 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 100 mg/4 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Pemetrexed (Ever Pharma) 1 g/40 mL injection, 40 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 500 mg/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Pemetrexed (Ever Pharma) 100 mg/4 mL injection, 4 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Pemetrexed (Ever Pharma) 500 mg/20 mL injection, 20 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Vaxelis injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Vaxelis injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| diphtheria + tetanus + pertussis 5 component + hepatitis B + polio trivalent + Haemophilus influenzae type b conjugate (PRP-OMP) vaccine, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Teriparatide (Lupin) 250 microgram/mL injection, 2.4 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Mytolac 120 mg/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Mytolac 90 mg/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Hyoscine Butylbromide (AFT) 20 mg/mL injection, 1 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Neorecormon (epoetin beta 5000 international units / 0.3 mL) injection, 0.3 mL syringe (trade product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Naloxone Min-I-Jet (CSL) 2 mg/5 mL injection, 5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Doxorubicin Hydrochloride (Ebewe) 200 mg/100 mL injection, 100 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| tigecycline 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| typhoid fever polysaccharide vaccine 25 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (100 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 10% (50 g/500 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (20 g/100 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (75 g/250 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| retinol palmitate 3500 units + colecalciferol 5.5 microgram + dl-alpha-tocopherol 10.2 mg (11.333 units) + ascorbic acid 125 mg + cocarboxylase tetrahydrate 5.8 mg + riboflavin sodium phosphate 5.67 mg + pyridoxine hydrochloride 5.5 mg + cyanocobalamin 6 microgram + folic acid 414 microgram + dexpanthenol 16.15 mg + biotin 69 microgram + nicotinamide 46 mg injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (99.9 g/333 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| drotrecogin alfa (activated) 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (200 g/L) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| drotrecogin alfa (activated) 5 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (100 g/500 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| anidulafungin 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (99.9 g/333 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (150 g/500 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (75 g/250 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (20 g/100 mL) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| methylene blue 50 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 10% (50 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (50 g/250 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 20% (200 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| soya oil 30% (300 g/L) injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium tetradecyl sulfate 0.2% (10 mg/5 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| acetylcysteine 2 g/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium tetradecyl sulfate 3% (150 mg/5 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| acetylcysteine 6 g/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| benzathine benzylpenicillin 1.2 million units (900 mg)/2.3 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| potassium acetate 2.45 g (potassium 25 mmol)/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| mitomycin 10 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| mitomycin 2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| mitomycin 20 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 5000 units/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| death adder antivenom 6000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 2000 units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide 100 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 7000 units/0.7 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide 50 mg/2.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 1000 units/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide 200 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 8000 units/0.8 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 3000 units/0.3 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide 1 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 6000 units/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| insulin isophane bovine 100 units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 9000 units/0.9 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 10 000 units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| etoposide 100 mg injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| etoposide 500 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| epoetin lambda 4000 units/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|